Insiders / Lyons Gary a

Lyons Gary a

CIK 1123343personinsider
Companies
2
First seen
Apr 16, 2026
Last activity
May 29, 2026

Companies

2View all →
CompanyRoleShares heldPeak heldTradesLatest
Neurocrine Biosciences Inc · NBIXDirector122,141122,1414—
Travere Therapeutics, Inc. · TVTXDirector61,50065,5005—

All securities held

5 positions · latest reported per filing
CompanySecuritySharesAs of
Neurocrine Biosciences IncCommon Stock122,141May 21, 2026
Neurocrine Biosciences IncNon-Qualified Stock OptionDerivative2,624May 27, 2026
Neurocrine Biosciences IncRestriced Stock UnitDerivative1,284May 27, 2026
Travere Therapeutics, Inc.Common Stock61,500May 19, 2026
Travere Therapeutics, Inc.Stock option (right to buy)Derivative12,000May 19, 2026

Activity

View all →
InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Apr 14, 2026SellTVTX
Travere Therapeutics, Inc.
Common Stock
$328.6K-8K
-12.21%
57,500
0.06% of shares
medium
Apr 14, 2026ExerciseTVTX
Travere Therapeutics, Inc.
Common Stock
$130.6K+8K
+13.91%
65,500
0.07% of shares
low
May 21, 2026ExerciseNBIX
Neurocrine Biosciences Inc
Common Stock
$0+2K
+1.38%
122,141
0.12% of shares
low
May 19, 2026GrantTVTX
Travere Therapeutics, Inc.
Common Stock
$0+4K
+6.96%
61,500
0.07% of shares
low
May 27, 2026GrantNBIX
Neurocrine Biosciences Inc
Non-Qualified Stock Option
—+3K
2,624
<0.01% of shares
low
May 27, 2026GrantNBIX
Neurocrine Biosciences Inc
Restriced Stock Unit
—+1K
1,284
<0.01% of shares
low
May 21, 2026ExerciseNBIX
Neurocrine Biosciences Inc
Restricted Stock Unit
—-2K
-100.00%
0
0.00% of shares
low
May 19, 2026GrantTVTX
Travere Therapeutics, Inc.
Stock option (right to buy)
—+12K
12,000
0.01% of shares
low
Apr 14, 2026ExerciseTVTX
Travere Therapeutics, Inc.
Stock option (right to buy)
—+8K
0
0.00% of shares
low